These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 16575740)
21. Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis. Barchiesi F; Hollis RJ; Del Poeta M; McGough DA; Scalise G; Rinaldi MG; Pfaller MA Clin Infect Dis; 1995 Sep; 21(3):561-4. PubMed ID: 8527544 [TBL] [Abstract][Full Text] [Related]
22. Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study. Gligorov J; Bastit L; Gervais H; Henni M; Kahila W; Lepille D; Luporsi E; Sasso G; Varette C; Azria D; Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):532-9. PubMed ID: 20594986 [TBL] [Abstract][Full Text] [Related]
23. Voriconazole resistant Candida spp. and Saccharomyces spp. isolates from oropharyngeal candidiasis from Cambodian children with AIDS not pretreated with azoles (letter). Shahum A; Liskova A; Kalavsky E; Krcmery V Scand J Infect Dis; 2007; 39(3):286-7. PubMed ID: 17366071 [No Abstract] [Full Text] [Related]
24. Rationalizing prescribing for oral and oesophageal candidiasis. Taylor CB; Finlay R; Richardson C; Bunting P; Welch J Int J STD AIDS; 1996 Oct; 7(6):452. PubMed ID: 8940678 [No Abstract] [Full Text] [Related]
26. Failure of all antifungal therapy for infection due to Candida albicans: a new AIDS-related problem? Landman D; Saurina G; Quale JM Clin Infect Dis; 1998 Jan; 26(1):183-4. PubMed ID: 9455530 [No Abstract] [Full Text] [Related]
27. [Fluconazole in the treatment of esophageal, bronchial and oral candidiasis in patients with ARC and AIDS]. Gritti FM; Raise E; Di Salvo S; Vannini V; Lanzoni G; Cucci AM G Ital Chemioter; 1988; 35(1-3):61-8. PubMed ID: 2855730 [No Abstract] [Full Text] [Related]
29. The diagnosis and treatment of candidiasis: current therapeutic options. Filler SG AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S10-4; discussion S15. PubMed ID: 11361745 [No Abstract] [Full Text] [Related]
30. Candida infection in HIV positive patients 1985-2007. Traeder C; Kowoll S; Arastéh K Mycoses; 2008 Sep; 51 Suppl 2():58-61. PubMed ID: 18721333 [TBL] [Abstract][Full Text] [Related]
31. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. Li X; Brown N; Chau AS; López-Ribot JL; Ruesga MT; Quindos G; Mendrick CA; Hare RS; Loebenberg D; DiDomenico B; McNicholas PM J Antimicrob Chemother; 2004 Jan; 53(1):74-80. PubMed ID: 14657086 [TBL] [Abstract][Full Text] [Related]
32. Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility. Makarova NU; Pokrowsky VV; Kravchenko AV; Serebrovskaya LV; James MJ; McNeil MM; Lasker BA; Warnock DW; Reiss E J Clin Microbiol; 2003 May; 41(5):1833-7. PubMed ID: 12734213 [TBL] [Abstract][Full Text] [Related]
33. Perillaldehyde: A promising antifungal agent to treat oropharyngeal candidiasis. Chen L; Qu S; Yang K; Liu M; Li YX; Keller NP; Zeng X; Tian J Biochem Pharmacol; 2020 Oct; 180():114201. PubMed ID: 32822688 [TBL] [Abstract][Full Text] [Related]